↓ Skip to main content

Fermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats

Overview of attention for article published in BMC Complementary Medicine and Therapies, November 2016
Altmetric Badge

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fermented rice bran supplementation mitigates metabolic syndrome in stroke-prone spontaneously hypertensive rats
Published in
BMC Complementary Medicine and Therapies, November 2016
DOI 10.1186/s12906-016-1427-z
Pubmed ID
Authors

Md Alauddin, Hitoshi Shirakawa, Takuya Koseki, Naoko Kijima, Ardiansyah, Slamet Budijanto, Jahidul Islam, Tomoko Goto, Michio Komai

Abstract

Previous study shown that enzyme treated-rice bran effectively improved hypertension and glucose intolerance in stroke-prone spontaneously hypertensive rat (SHRSP). However, dual fermentation of rice bran's efficacy against metabolic syndrome in SHRSP is still unknown. Fermented rice bran (FRB) was prepared by dual fermentation of rice bran using fungi and lactic acid bacteria. The effect of FRB on metabolic syndrome in stroke-prone spontaneously hypertensive rats (SHRSP) was investigated by single and chronic supplementation. Dual fermentation of rice bran enriches the functional value of rice bran. Single-dose oral administration of FRB (2 g/kg body weight) reduced systolic blood pressure; however, chronic supplementation with 5 % FRB (4 weeks) significantly reduced both systolic and diastolic blood pressure. FRB supplementation improved leptin impairment and increased serum adiponectin levels and angiotensin-converting enzyme inhibitory activity. Furthermore, FRB supplementation improved glucose tolerance and insulin sensitivity as well as serum insulin levels. Lipid profiles were also improved by the regulation of 5' adenosine monophosphate-activated protein kinase activation. Moreover, supplementation with FRB reduced the expressions of hepatic transcription factors such as liver X receptor alpha, sterol regulatory element-binding protein 1c, and carbohydrate-responsive element-binding protein alpha, as well as their target genes. In conclusion, dietary supplementation with FRB may lower hypertension and alleviate metabolic syndrome. Metabolic syndrome was better alleviated with FRB supplementation. We therefore suggest FRB as an alternative medicine to reduce the risks of lifestyle-related diseases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 76 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 13%
Student > Master 10 13%
Student > Bachelor 8 10%
Lecturer 5 6%
Student > Doctoral Student 3 4%
Other 11 14%
Unknown 30 39%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 14%
Medicine and Dentistry 9 12%
Biochemistry, Genetics and Molecular Biology 7 9%
Nursing and Health Professions 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 7 9%
Unknown 35 45%